Quality Review
Meet the Q&PS Team
MedicASK Answers
MedicASK Answers Full List
Patient Safety Incident Report
Loss or theft of controlled substances
MedicASK
Files
TXA and Tourniquet
Question# 965
If a patient has a major arterial bleed and it has been controlled by a tourniquet.
Prior to bleeding being controlled they lost a significant amount of blood and are now hypotensive and tachycardic. meeting indications for TXA.
Would TXA still be considered if the bleeding is controlled?
Prior to bleeding being controlled they lost a significant amount of blood and are now hypotensive and tachycardic. meeting indications for TXA.
Would TXA still be considered if the bleeding is controlled?
Answer:
We want to take this opportunity to emphasize that controlling bleeding is always the top priority. Immediate measures—such as applying a tourniquet to a bleeding extremity or direct pressure to a central wound—should be taken first whenever possible, as they can rapidly control active hemorrhage. While TXA can be beneficial, it does not act quickly enough to stop active bleeding on its own and should not replace these initial interventions.
In the context of your question, yes, Tranexamic acid (TXA) would still be indicated in this scenario even once arterial bleeding has been controlled with a tourniquet.
TXA is an antifibrinolytic agent which means that it works by inhibiting fibrinolysis and stabilizing formed clots. In a patient who has already experienced significant blood loss and now meets the medical directive indications with hypotension or tachycardia, there is a high risk of trauma-induced coagulopathy and ongoing microscopic bleeding, even if the obvious external hemorrhage is no longer active. The presence of shock is a key driver for TXA use, not just visible bleeding.
Evidence from studies such as the CRASH-2 trial supports administering TXA in trauma patients with significant hemorrhage or signs of shock, regardless of whether bleeding has been fully controlled. The benefit is strongly time-dependent, with the greatest effect seen when TXA is given as early as possible and within 3 hours of injury. In this case, the patient’s prior major arterial bleed and current hemodynamic instability meet standard indications, so TXA would still be appropriate despite successful tourniquet application.
In the context of your question, yes, Tranexamic acid (TXA) would still be indicated in this scenario even once arterial bleeding has been controlled with a tourniquet.
TXA is an antifibrinolytic agent which means that it works by inhibiting fibrinolysis and stabilizing formed clots. In a patient who has already experienced significant blood loss and now meets the medical directive indications with hypotension or tachycardia, there is a high risk of trauma-induced coagulopathy and ongoing microscopic bleeding, even if the obvious external hemorrhage is no longer active. The presence of shock is a key driver for TXA use, not just visible bleeding.
Evidence from studies such as the CRASH-2 trial supports administering TXA in trauma patients with significant hemorrhage or signs of shock, regardless of whether bleeding has been fully controlled. The benefit is strongly time-dependent, with the greatest effect seen when TXA is given as early as possible and within 3 hours of injury. In this case, the patient’s prior major arterial bleed and current hemodynamic instability meet standard indications, so TXA would still be appropriate despite successful tourniquet application.